Marketing

Pharma marketers weigh economy and chance of TV ad ban during upfronts season

Pharma remains the last port in the storm for TV spending, but the sector’s moving to digital channels.

Related Coverage

• After years of caution, pharma advertisers are embracing influencer marketing
• Future of TV Briefing: Trump’s tariffs are making flexibility an upfront focal point yet again
• Media buyers anticipate a slower TV upfronts season amid economic uncertainty